Century Therapeutics, Inc.
US ˙ NasdaqCM ˙ US15673T1007

SecurityIPSC / Century Therapeutics, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership230,820 shares
Latest Disclosed Value $ 521,653
Northern Trust Corp reports 119.72% increase in ownership of IPSC / Century Therapeutics, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 230,820 shares of Century Therapeutics, Inc. (US:IPSC) valued at $521,653 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 105,052 shares of Century Therapeutics, Inc.. This represents a change in shares of 119.72% during the quarter. The current value of the position is $507,804 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CENTURY THERAPEUTICS COM 15673T100 230,820 125,768 119.72 522 400.96 0.0000
2026-02-17 2025-12-31 13F CENTURY THERAPEUTICS COM 15673T100 105,052 38,052 56.79 105 215.15 0.0000
2025-11-14 2025-09-30 13F CENTURY THERAPEUTICS COM 15673T100 67,000 0 0.00 33 -10.81 0.0000
2025-08-13 2025-06-30 13F CENTURY THERAPEUTICS COM 15673T100 67,000 -222,601 -76.86 37 -72.99 0.0000
2025-05-13 2025-03-31 13F CENTURY THERAPEUTICS COM 15673T100 289,601 -47,388 -14.06 138 -59.71 0.0000
2025-02-14 2024-12-31 13F CENTURY THERAPEUTICS COM 15673T100 336,989 -15,523 -4.40 340 -43.52 0.0000
2024-11-13 2024-09-30 13F CENTURY THERAPEUTICS COM 15673T100 352,512 141,186 66.81 603 11.90 0.0001
2024-08-14 2024-06-30 13F CENTURY THERAPEUTICS COM 15673T100 211,326 26,711 14.47 539 -30.22 0.0001
2024-05-14 2024-03-31 13F CENTURY THERAPEUTICS COM 15673T100 184,615 -1,364 -0.73 772 24.96 0.0001
2024-02-13 2023-12-31 13F CENTURY THERAPEUTICS COM 15673T100 185,979 -1,215 -0.65 617 64.97 0.0001
2023-11-13 2023-09-30 13F CENTURY THERAPEUTICS COM 15673T100 187,194 7,074 3.93 374 -34.27 0.0001
2023-08-11 2023-06-30 13F CENTURY THERAPEUTICS COM 15673T100 180,120 17,447 10.73 569 0.89 0.0001
2023-05-15 2023-03-31 13F CENTURY THERAPEUTICS COM 15673T100 162,673 -4,620 -2.76 564 -34.27 0.0001
2023-02-13 2022-12-31 13F CENTURY THERAPEUTICS COM 15673T100 167,293 3,778 2.31 858 -46.94 0.0002
2022-11-14 2022-09-30 13F CENTURY THERAPEUTICS COM 15673T100 163,515 13,574 9.05 1,617 28.44 0.0004
2022-08-12 2022-06-30 13F CENTURY THERAPEUTICS COM 15673T100 149,941 15,457 11.49 1,259 -25.63 0.0003
2022-05-13 2022-03-31 13F CENTURY THERAPEUTICS COM 15673T100 134,484 31,317 30.36 1,693 3.48 0.0003
2022-02-08 2021-12-31 13F CENTURY THERAPEUTICS COM 15673T100 103,167 -621 -0.60 1,636 -37.34 0.0003
2021-11-15 2021-09-30 13F CENTURY THERAPEUTICS COM 15673T100 103,788 103,788 2,611 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.